Liminatus Pharma LIMN 深 沪
等待开盘 05-20 09:30:00 美东时间
0.19
+0.003
+1.55%
华盛通- 最 高0.192
- 今 开0.1886
- 成交量 59.66万股
- 最 低 0.18
- 昨 收 0.1871
- 总市值 852.68万
- 52周最高 33.66
- 市盈率 静 --
- 换手率 1.33%
- 52周最低 0.1592
- 委 比 51.49%
- 总股本 4487.76万
- 历史最高 33.66
- 量 比 0.77
- 振 幅 6.41%
- 历史最低 0.1592
- 每 手 1
- 风险率 4.80%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why NN Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
NN Inc. (NNBR) rose in pre-market trading after announcing expected sales growth and raising full-year guidance. Other gainers include NICM, AGAE, IMMP, LIMN, CIIT, MLSS, LAES, GBR, and STNE. Losers include SNAL, MIMI, ARAI, and SURG.
04-15 16:51
Liminatus Intends To Start Phase 1 Clinical Study Of CD47-Blocking Monoclonal Antibody
Liminatus today announced plans to initiate a Phase 1 clinical trial evaluating IBA101, a next-generation CD47-blocking monoclonal antibody designed to engage innate immune pathways and complement established
03-17 20:14
Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody
Liminatus announced plans to initiate a Phase 1 clinical trial for IBA101, a next-generation CD47-blocking monoclonal antibody designed to enhance immune system engagement against cancer cells. The trial will evaluate the safety, tolerability, and effectiveness of IBA101, both as monotherapy and in combination with PD-1/PD-L1 inhibitors, initially focusing on lung cancer. The study, led by Dr. Se-Hoon Lee, aims to provide early insights into the ...
03-17 12:08
Gold Down 3%; Medtronic Earnings Top Views
U.S. stocks traded mostly lower midway through trading, with the Nasdaq Composi...
02-18 01:14
Liminatus Pharma shares are trading lower after the company announced pricing of $4.0 million public offering.
Liminatus Pharma shares are trading lower after the company announced pricing o...
02-18 01:00
US Stocks Mixed; NY Manufacturing Activity Falls In February
U.S. stocks traded mixed this morning, with the Dow Jones index gaining around ...
02-17 22:46
Liminatus Announces $4M Public Offering; 13,813,000 Common Stock Shares On Offer At $0.29/Share
Gross proceeds, before deducting placement agent fees and other estimated offering expenses, are expected to be approximately $4.0 million. The potential additional gross proceeds to the Company from the exercise of the
02-17 21:47
Liminatus Pharma Announces $4 Million Public Offering With Warrants
Liminatus Pharma Announces $4 Million Public Offering With Warrants Liminatus Pharma Inc. has announced the pricing of a public offering, including 13,813,000 shares of common stock and warrants to purchase up to 20,719,500 shares at an exercise price of $0.29 per share. The warrants are immediately
02-17 21:44
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering
Liminatus Pharma announced the pricing of a public offering of 13.8 million shares and warrants for up to 20.7 million shares at $0.29 per share. Total gross proceeds are estimated at $4 million, with potential additional $6 million from warrant exercised. Proceeds will fund working capital and advance business goals. Maxim Group is the placement agent, and the offering is under SEC registration.
02-17 13:44
BUZZ-U.S. STOCKS ON THE MOVE-Micron, McDonald's, Generac
BUZZ-U.S. STOCKS ON THE MOVE-Micron, McDonald's, Generac Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street indexes lost steam on Wednesday following a renewed selloff in so
02-12 02:38
